INSP Inspire Medical Systems, Inc. SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Best Medical Devices Stocks 2026 →

Inspire Medical Systems (INSP) Stock: Buy, Sell, or Hold?

$62.31
-2.02 (-3.14%) ▼
5d: +0.66% 30d: -12.84% 90d: +6.91%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (55%)
Quality Score
54/100
Position
OVERSOLD
30-Day Fair Range
$65.71 – $71.41
Position: OVERSOLD
Forward P/E & Valuation
41.7x FAIR
vs 38.7x historical avg
Wall Street Target
$69.63
+11.7% upside
Options IV & Volume
42th pct IV
HIGH volume confirmation
Support / Resistance
$60.20 / $71.99
Trend: Strong Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: INSP is fairly valued with market pricing in 2.5% annual growth. Fine to hold or accumulate slowly on dips.

Get Alerted When INSP Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$58.69
Based on 9.5% avg growth
INTRINSIC VALUE TODAY
$36.44
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: INSP is currently trading at $62.31, which is considered oversold relative to its 30-day fair value range of $65.71 to $71.41. The stock's valuation (Forward PE: 41.6) is in line with its historical norms (38.7). At these levels, the market is pricing in 2.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, INSP is in a strong uptrend. Immediate support is located at $60.20, while resistance sits at $71.99. Short-term momentum is weak, with the stock down 3.1% recently.

Market Sentiment: INSP scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $69.62 (+11.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $65.71 - $71.41
Company Quality Score 54/100 (HOLD)
Options IV Signal 42th percentile (NORMAL)
Volume Confirmation HIGH
Confidence Score 54.6%

Trading Range & Key Levels

30-Day Trading Range $65.71 - $71.41
Current vs Trading Range OVERSOLD
Expected Move (7 Days) ±$5.48 (8.8%)
Support Level $60.20
Resistance Level $71.99
Current Trend Strong Uptrend
Technical data as of Nov 10, 2026

Protect Your Profits

Holding INSP? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Options fairly priced (IV 42th percentile)
  • BEARISH: Weak technical setup (32/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-3.1%)
  • BULLISH: Trading below Wall St target ($69.62)
  • NEUTRAL: Market pricing in 2.5% annual earnings growth - fairly valued

Fundamental Context

Forward P/E (Next Year Est.) 41.65
Wall Street Target $69.63 (+11.7%)
Revenue Growth (YoY) -7.9%
Earnings Growth (YoY) 308.4%
Profit Margin 11.4%
Valuation Premium vs History +2.5% premium
PE vs Historical 41.7 vs 38.7 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +2.5% (market-implied from PE analysis)
1-Year Target $63.87 (+3%)
2-Year Target $65.46 (+5%)
3-Year Target $67.10 (+8%)
3-Yr Target (if PE normalizes) (PE: 42→39) PE COMPRESSION $62.35 (+0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 41.6, Growth: 15.0%) $94.84 (+52%)
Base: (SPY PE: 19.9, Growth: 15.0%) $45.23 (-27%)
Bear: (PE: 16.9, Growth: 15.0%) $38.44 (-38%)
📈 Valuation based on Current Earnings
Trailing PE: 19.20 | Current EPS (TTM): $3.35
Bull Case $35.38 (-43%)
Analyst growth -50.0%, PE expands to 21.1
Base Case $32.17 (-48%)
Market implied -50.0%, PE stable at 19.2
Bear Case $43.74 (-30%)
Severe decline -20.0%, PE contracts to 16.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share INSP Analysis

Share this live INSP analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (INSP)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 3, 2026
Daily AI digest
AI Retail Discussion Summary: Medical technology company Inspire Medical Systems reported Q3 2026 earnings, beating sales expectations and raising full-year guidance, despite a year-on-year revenue decline.
Key Retail Themes: earnings beat revenue decline full-year guidance increase
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 5:30 AM ET
Data refreshes hourly during market hours. Next update: 6:30 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for INSP.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
DXCM
DexCom Inc
STRONG BUY
29 analysts
$98 47 HOLD
BSX
Boston Scientific Corp
BUY
31 analysts
$50 53 HOLD
MDT
Medtronic PLC
BUY
30 analysts
$105 35 SELL
PODD
Insulet Corporation
BUY
26 analysts
$178 43 HOLD
TNDM
Tandem Diabetes Care Inc
BUY
25 analysts
$28 49 HOLD

Advanced INSP Option Strategies

Professional options setups generated by AI based on today's INSP price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive INSP Research Pages
INSP Technical Chart INSP Price Prediction INSP Intrinsic Value DCF INSP Earnings Date Why is INSP Moving Today? INSP Investment Advisor INSP Fair Price Analyzer INSP Options Chain INSP Options Advisor INSP Options Analysis INSP Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals